[HTML][HTML] PREVENtion of HeartMate II pump thrombosis through clinical management: the PREVENT multi-center study
Background Recommended structured clinical practices including implant technique, anti-
coagulation strategy, and pump speed management (PREVENT [PREVENtion of HeartMate …
coagulation strategy, and pump speed management (PREVENT [PREVENtion of HeartMate …
Left ventricular assist devices: challenges toward sustaining long-term patient care
M Schmid Daners, F Kaufmann, R Amacher… - Annals of biomedical …, 2017 - Springer
Over the last few decades, the left ventricular assist device (LVAD) technology has been
tremendously improved transitioning from large and noisy paracorporeal volume …
tremendously improved transitioning from large and noisy paracorporeal volume …
New management strategies in heart failure
AT Owens, SC Brozena, M Jessup - Circulation Research, 2016 - Am Heart Assoc
Despite> 100 clinical trials, only 2 new drugs had been approved by the US Food and Drug
Administration for the treatment of chronic heart failure in more than a decade: the …
Administration for the treatment of chronic heart failure in more than a decade: the …
Bioprosthetic total artificial heart in autoregulated mode is biologically hemocompatible: Insights for multimers of von willebrand factor
B Poitier, R Chocron, C Peronino… - … and Vascular Biology, 2022 - Am Heart Assoc
Background: Carmat bioprosthetic total artificial heart (Aeson; A-TAH) is a pulsatile and
autoregulated device. The aim of this study is to evaluate level of hemolysis potential …
autoregulated device. The aim of this study is to evaluate level of hemolysis potential …
High fidelity computational simulation of thrombus formation in Thoratec HeartMate II continuous flow ventricular assist device
Continuous flow ventricular assist devices (cfVADs) provide a life-saving therapy for severe
heart failure. However, in recent years, the incidence of device-related thrombosis (resulting …
heart failure. However, in recent years, the incidence of device-related thrombosis (resulting …
Hydraulic characterization of implantable rotary blood pumps
S Boës, B Thamsen, M Haas… - IEEE Transactions …, 2018 - ieeexplore.ieee.org
Objective: The hydraulic properties of implantable rotary blood pumps (RBPs) determine
their interaction with the cardiovascular system. A systematic comparison in this regard has …
their interaction with the cardiovascular system. A systematic comparison in this regard has …
[HTML][HTML] Blood trauma potential of the HeartWare Ventricular Assist Device in pediatric patients
Objective Mechanical circulatory support has become a standard therapy for adult patients
with end-stage heart failure. For pediatric patients, technologic development lags behind …
with end-stage heart failure. For pediatric patients, technologic development lags behind …
von Willebrand factor disruption and continuous-flow circulatory devices
AG Proudfoot, SJ Davidson, M Strueber - The Journal of Heart and Lung …, 2017 - Elsevier
Bleeding events remain a significant and frequent complication of continuous-flow left
ventricular assist devices (VADs). von Willebrand factor (VWF) is critical to hemostasis by …
ventricular assist devices (VADs). von Willebrand factor (VWF) is critical to hemostasis by …
Visualization and analysis of biomaterial-centered thrombus formation within a defined crevice under flow
The blood flow pathway within a device, together with the biomaterial surfaces and status of
the patient's blood, are well-recognized factors in the development of thrombotic deposition …
the patient's blood, are well-recognized factors in the development of thrombotic deposition …
A long-term mechanical cavopulmonary support device for patients with Fontan circulation
In patients with a single ventricle, failure of the cardiovascular system may be prevented by
substituting the missing sub-pulmonary ventricle with a pump. The aim of this study was to …
substituting the missing sub-pulmonary ventricle with a pump. The aim of this study was to …